Publicación:
Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence Among Adults in a Tropical City of the Caribbean Area, Colombia: Are We Much Closer to Herd Immunity Than Developed Countries?

Vista sencilla de ítem
dc.contributor.authorMattar Velilla, Ameth Salim
dc.contributor.authorAlvis Guzmán, Nelson
dc.contributor.authorGaray Montalvo, Evelin
dc.contributor.authorRivero, Ricardo
dc.contributor.authorGarcía Pérez, Alejandra
dc.contributor.authorBotero, Yesica
dc.contributor.authorMiranda Regino, Jorge Luis
dc.contributor.authorGaleano Anaya, Ketty Esther
dc.contributor.authorDe la Hoz, Fernando
dc.contributor.authorMartínez Bravo, Caty Milena
dc.contributor.authorArrieta Bernate, Germán Javier
dc.contributor.authorFaccini Martínez, Álvaro Adolfo
dc.contributor.authorGuzmán Terán, Camilo Antonio
dc.contributor.authorKerguelen, Hugo
dc.contributor.authorMoscote, María
dc.contributor.authorContreras, Héctor
dc.contributor.authorContreras Cogollo, Veronica
dc.contributor.corporatenameCorporación Universitaria del caribe - CECAR
dc.contributor.researchgroupSalud Pública y Auditoría en Salud
dc.date.accessioned2025-08-28T20:24:03Z
dc.date.issued2020
dc.description.abstractA serological survey was carried out in Monteria (500 000 population), a mid-size city in Colombia. An overall prevalence of 55.3% (95% confidence interval, 52.5%–57.8%) was found among a sample of 1.368 people randomly selected from the population. Test positivity was related to economic characteristics with the highest prevalence found in the most impoverished areas, representing 83.8% of the city’s population. We found a prevalence that might be associated with some important level of population immunity.
dc.description.researchareaAuditoría en Salud
dc.description.researchareaSalud Pública
dc.format.extent4 páginas
dc.format.mimetypeapplication/pdf
dc.identifier.eissn2328-8957
dc.identifier.urihttps://repositorio.cecar.edu.co/handle/cecar/10798
dc.language.isoeng
dc.publisher.placeColombia
dc.relation.citationendpage4
dc.relation.citationstartpage1
dc.relation.citationvolumeVolumen 13
dc.relation.ispartofjournalOpen Forum Infectious Diseases
dc.relation.referencesDe la Hoz-Restrepo F, Alvis-Zakzuk NJ, De la Hoz-Gomez JF, et al. Is Colombia an example of successful containment of the 2020 COVID-19 pandemic? A critical analysis of the epidemiological data, March to July 2020. Int J Infect Dis 2020; 99:522–9.
dc.relation.referencesEckerle I, Meyer B. SARS-CoV-2 seroprevalence in COVID-19 hotspots. Lancet 2020; 396:514–5.
dc.relation.referencesFaccini-Martinez A, Rivero R, Garay E, et al. Serological cross-reactivity using a SARS-CoV-2 ELISA test in acute Zika virus infection, Colombia, Int J Infect Dis 2020; 101:191–3.
dc.relation.referencesDel Brutto OH, Costa AF, Mera RM, et al. SARS-CoV-2 in rural Latin America. A population-based study in coastal Ecuador. Clin Infect Dis 2020; doi: 10.1093/ cid/ciaa1055/5876901.
dc.relation.referencesPollán M, Pérez-Gómez B, Pastor-Barriuso R, et al.; ENE-COVID Study Group. Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, populationbased seroepidemiological study. Lancet 2020; 396:535–44.
dc.relation.referencesGudbjartsson DF, Helgason A, Jonsson H, et al. Spread of SARS-CoV-2 in the Icelandic population. N Engl J Med 2020; 382:2302–15.
dc.relation.referencesXu X, Sun J, Nie S, et al. Author correction: Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China. Nat Med 2020; 26:1494.
dc.relation.referencesLustig Y, Keler S, Kolodny R, et al. Potential antigenic cross-reactivity between SARS-CoV-2 and dengue viruses. Clin Infect Dis 2020; doi: 10.1093/cid/ciaa1207.
dc.relation.referencesSpinicci M, Bartoloni A, Mantella A, et al. Low risk of serological cross-reactivity between dengue and COVID-19. Mem Inst Oswaldo Cruz 2020; 115:e200225.
dc.relation.referencesHanson KE, Caliendo AM, Arias CA, et al. Infectious Diseases Society of America guidelines on the diagnosis of COVID-19. Clin Infect Dis 2020; doi: 10.1093/cid/ ciaa760.
dc.relation.referencesEuropean Centre for Disease Prevention and Control. Reinfection with SARSCoV: considerations for public health response: ECDC; 2020. Available at: https:// www.ecdc.europa.eu/sites/default/files/documents/Re-infection-and-viralshedding-threat-assessment-brief.pdf. Accessed 14 October 2020.
dc.rightsDerechos reservados - Corporación Universitaria de Caribe - CECAR
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess
dc.rights.coarhttp://purl.org/coar/access_right/c_abf2
dc.rights.licenseAtribución-NoComercial 4.0 Internacional (CC BY-NC 4.0)
dc.rights.urihttps://creativecommons.org/licenses/by-nc/4.0/
dc.sourceDOI: 10.1093/ofid/ofaa550
dc.subject.proposalCoronavirus
dc.subject.proposalELISA
dc.subject.proposalInfectious disease transmission
dc.subject.proposalPoverty areas
dc.subject.proposalSocioeconomic status
dc.titleSevere Acute Respiratory Syndrome Coronavirus 2 Seroprevalence Among Adults in a Tropical City of the Caribbean Area, Colombia: Are We Much Closer to Herd Immunity Than Developed Countries?eng
dc.typeArtículo de revista
dc.type.coarhttp://purl.org/coar/resource_type/c_2df8fbb1
dc.type.coarversionhttp://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.contentText
dc.type.driverinfo:eu-repo/semantics/article
dc.type.redcolhttp://purl.org/redcol/resource_type/ART
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dspace.entity.typePublication

Archivos

Bloque original

Mostrando 1 - 1 de 1
Miniatura
Nombre:
Severe Acute Respiratory Syndrome.pdf
Tamaño:
313.09 KB
Formato:
Adobe Portable Document Format
Descargar

Bloque de licencias

Mostrando 1 - 1 de 1
Miniatura
Nombre:
license.txt
Tamaño:
14.49 KB
Formato:
Item-specific license agreed upon to submission
Descripción:
Descargar

Colecciones

BAF. Salud Pública y Auditoria en Salud (SPAS)